Ocumension Therapeutics (HKG:1477)
7.33
+0.37 (5.32%)
At close: Mar 27, 2026
Ocumension Therapeutics Employees
Ocumension Therapeutics had 505 employees as of June 30, 2025. The number of employees increased by 16 or 3.27% since the number was reported on December 31, 2024.
Employees
505
Change
16
Growth
3.27%
Revenue / Employee
1.77M HKD
Profits / Employee
-349.97K HKD
Market Cap
5.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 505 | 16 | 3.27% |
| Dec 31, 2024 | 489 | 45 | 10.14% |
| Dec 31, 2023 | 444 | 46 | 11.56% |
| Dec 31, 2022 | 398 | 262 | 192.65% |
| Dec 31, 2020 | 136 | 95 | 231.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,156 |
| Viva Biotech Holdings | 2,063 |
| CK Life Sciences Int'l., (Holdings) | 1,920 |
| Shandong Boan Biotechnology | 714 |
| BioDlink International Company | 604 |
| Alphamab Oncology | 484 |
| Qyuns Therapeutics | 337 |
| Abbisko Cayman | 226 |